After more than two decades without a human vaccine for Lyme…
Category: Viruses
Home /
For more than 15 years, virologist Chris Buck has worked to…
Since emerging from China in 1996, bird flu has reshaped ecosystems…
Diphtheria is a preventable bacterial disease that causes a thick membrane…
Researchers have discovered a surprising way to deliver vaccines: with dental…
Cold and flu medicine likely isn’t your idea of a tasty…
Since their discovery in the late 1800s, viruses have been considered…
As part of a research partnership aimed at improving the delivery…
Biotech start-up Ring Therapeutics, founded by Flagship Pioneering in 2017, hopes…
RNA viruses are known to cause a large number of diseases…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
Webinars
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
Clinical Trial Results Revive Long-Awaited Lyme Disease Vaccine Effort
May 13, 2026
After more than two decades without a human vaccine for Lyme disease, a new candidate is showing measurable progress. Clinical trial data reported by Pfizer
Brewing Immunity: The Science and Controversy of Vaccine Beer
March 16, 2026
For more than 15 years, virologist Chris Buck has worked to develop a vaccine against BK polyomavirus, a pathogen that quietly infects most people but
When Bird Flu Finds New Wings: Bats Enter the H5N1 Picture
January 12, 2026
Since emerging from China in 1996, bird flu has reshaped ecosystems in Asia, Europe, Africa and North and South America. Now the virus has found
When Old Diseases Roar Back: Understanding Diphtheria’s Resurgence
December 8, 2025
Diphtheria is a preventable bacterial disease that causes a thick membrane to form in the back of the throat, making swallowing and breathing difficult. It
Flossing for Immunity: How Dental String Could Deliver Future Vaccines
September 29, 2025
Researchers have discovered a surprising way to deliver vaccines: with dental floss. The idea came in response to a long-standing challenge in medicine—how to deliver
Chew on This: How Chewing Gum Could Fight the Flu
May 14, 2025
Cold and flu medicine likely isn’t your idea of a tasty treat. But what if tackling the flu was as easy as chewing a piece
Cheating & Cooperating: How Viruses Communicate
June 19, 2024
Since their discovery in the late 1800s, viruses have been considered simple organisms largely incapable of communication. But today’s virologists have changed their tune; now,
Lilly/Entos Deal Reinforces the Significance of Delivery Mechanisms for Nucleic Acid-Based Therapies
March 21, 2022
As part of a research partnership aimed at improving the delivery of nucleic acid-based therapies targeting nervous system diseases, American pharmaceutical company Eli Lilly and
Move Over AAV – Anelloviruses May Be Key to NextGen Gene Therapy
September 27, 2021
Biotech start-up Ring Therapeutics, founded by Flagship Pioneering in 2017, hopes to transform gene therapy by using a new class of vector — anelloviruses –
Understanding How Cells Tell RNA and DNA Apart Could Lead to New Antivirals
May 17, 2021
RNA viruses are known to cause a large number of diseases in humans, including COVID-19, measles, influenza, hepatitis, yellow fever and Zika. Most new and
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…